Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Purpose To investigate whether the blood-brain barrier (BBB) leaks blood-circulating substances in patients with early forms of Alzheimer disease (AD), and if so, to examine the extent and pattern of leakage. Materials and Methods This study was approved by the local medical ethical committees of the Maastricht University Medical Center and Leiden University Medical Center, and written informed consent was obtained from all subjects. For this pilot study, 16 patients with early AD and 17 healthy age-matched control subjects underwent dynamic contrast material–enhanced magnetic resonance (MR) imaging sequence with dual time resolution for 25 minutes. The Patlak graphical approach was used to quantify the BBB leakage rate and local blood plasma volume. Subsequent histogram analysis was used to determine the volume fraction of the leaking brain tissue. Differences were assessed with linear regression analysis, adjusted for confounding variables. Results The BBB leakage rate was significantly higher in patients compared with that in control subjects in the total gray matter (P < .05) and cortex (P = .03). Patients had a significantly higher volume fraction of the leaking brain tissue in the gray matter (P = .004), normal-appearing white matter (P < .04), deep gray matter (P = .01), and cortex (P = .004). When all subjects were considered, scores on the Mini-Mental State Examination decreased significantly with increasing leakage in the deep gray matter (P = .007) and cortex (P < .05). Conclusion The results of this study showed global BBB leakage in patients with early AD that is associated with cognitive decline. A compromised BBB may be part of a cascade of pathologic events that eventually lead to cognitive decline and dementia. ©RSNA, 2016 Online supplemental material is available for this article. An earlier incorrect version of this article appeared online. This article was corrected on October 24, 2016.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent neuroimaging studies in individuals with mild cognitive impairment (MCI) and early AD reveal BBB breakdown in the hippocampus, including its CA1 and dentate gyrus subfields (421), and several gray and white matter regions (220-222), respectively, before brain atrophy and dementia.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [220]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“BBB leakiness is seen both with normal ageing and AD [124,125].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [125]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the BBB disruption and increased permeability have been shown to occur in the early phase of the AD pathology (van de Haar et al., 2016).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as van de Haar et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Research works printed but not linked: 1
- Butman J, 2006, Proceedings of the Fourteenth Meeting of the International Society for Magnetic Resonance in Medicine, 1535
Cited by
Items 501–600 of 653
Qiu, J., Peng, S., Qu, R., Wu, L., Xing, L., Zhang, L., & Sun, J. (2024) · Clinical Science · doi:10.1042/cs20241658 · Cited by 3
Kim, T. K., Hong, J., Kim, J., Kim, K. H., Han, S. J., Kim, I., Oh, H., Jo, D., & Yim, J. H. (2024) · Molecules · doi:10.3390/molecules29225223 · Cited by 3
New Research on Biomarkers in Alzheimer’s Continuum
Vecchio, I., & Colica, C. (2025) · Reviews on Recent Clinical Trials · doi:10.2174/0115748871331138250114052615 · Cited by 3
Bateman, G. A., & Bateman, A. R. (2025) · Brain Sciences · doi:10.3390/brainsci15030269 · Cited by 3
Blood–Brain Barrier in Alzheimer's Disease
Brito, M. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813146-6.00025-4 · Cited by 3
Applications of Taurine in the Central Nervous System Disorders Linked with Mitochondrial Impairment
Heidari, R., & Ommati, M. M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124484123010005 · Cited by 3
Andreadou, E. G., Katsipis, G., Tsolaki, M., & Pantazaki, Α. A. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100091 · Cited by 3
Soyer, A., Goutal, S., Leterrier, S., Marie, S., Larrat, B., Selingue, E., Winkeler, A., Sarazin, M., Bottlaender, M., & Tournier, N. (2024) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2024.04.004 · Cited by 3
Carnevale, L., & Lembo, G. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae165 · Cited by 3
Dickie, B., & van Houdt, P. J. (2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-95209-5.00016-7 · Cited by 2
Jahng, G., Lee, M. B., & Kwon, O. I. (2025) · Scientific Reports · doi:10.1038/s41598-025-92966-x · Cited by 2
The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?
Chatanaka, M. K., Prassas, I., Masters, C. L., & Diamandis, E. P. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70484 · Cited by 2
Soluble epoxide hydrolase drives neurovascular dysfunction in a model of amyloidosis
DeMeglio, M., Biasi, E. S. D., Breunig, P., Candlish, M., Sauerland, C., Günther, S., Kawase, H., Peguera, B., Bohnstaedt, C., Herms, J. W., et al. (2026) · Brain · doi:10.1093/brain/awag184 · Cited by 2
microRNAs Mediate Signaling Pathways in Alzheimer’s Disease: Biomarkers and Therapeutic Targets
Rezayof, A., Ghasemzadeh, Z., & Kouhkan, F. (2024) · Springer eBooks · doi:10.1007/978-3-030-80662-0_39 · Cited by 2
Kolotilov, N. (2021) · Radiation Diagnostics Radiation Therapy · doi:10.37336/2707-0700-2021-2-3 · Cited by 2
Bae, J., Qayyum, S., Zhang, J., Das, A. B., Reyes, I., Aronowitz, E., Stavarache, M. A., Kaplitt, M. G., Masurkar, A. V., & Kim, S. (2024) · Journal of Neuroimaging · doi:10.1111/jon.13199 · Cited by 2
Imaging of enlarged perivascular spaces in Alzheimer’s disease with MRI techniques
Ma, W., Wang, X., & Wu, R. (2024) · Radiology Science · doi:10.15212/radsci-2024-0002 · Cited by 2
A vér–agy gát működése, öregedése és diszfunkciója. Átjutás a barrieren
Erdő, F., Hutka, B., & Dénès, L. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30633 · Cited by 2
Angiotensin Receptor Blocker Protects Alzheimer’s Disease Brain From Ischemic Insult
Takeda, S., & Morishita, R. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw158 · Cited by 2
Neurovascular-modulationPreprint
Khadka, N., & Bikson, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.21.214494 · Cited by 2
van de Haar, H. J. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20161110hh · Cited by 2
Sathyaseelan, C., Sadowski, M., Yang, Q., Ray, A., Wang, R., Thomas, L. F., Fuentes, R. P., Tabar, M. S., Cui, B., Jian, X., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7279662/v1 · Cited by 2
Nzou, G. (2019) · WakeSpace Scholarship (Wake Forest University) · Cited by 2
Lee, J., Han, Y., Jang, J. H., Lee, H., Park, J. H., Hwang, I., Chung, J. W., Choi, S. H., & Choi, K. S. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.111036 · Cited by 1
Bao, W., Chen, H., Zhang, Z., Wu, J., Lin, J., Tang, D., & Liu, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-20235-y · Cited by 1
Mural Cells, Microvessels, and Alzheimer’s Disease
Bonney, S. K., Nielson, C. D., & Shih, A. Y. (2025) · Physiology in health and disease · doi:10.1007/978-3-031-99609-2_15 · Cited by 1
van Delft, M. A. M., Cegiel, A., van Egmond, M., & Boon, L. (2025) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2025.10005 · Cited by 1
EHD4 and ASAP2 are critical negative regulators of the claudin‐5‐based endothelial barrier
Hashimoto, Y., Porkoláb, G., Hudson, N., O’Callaghan, J., Hanley, N., Delaney, C. P., Deli, M. A., Westenskow, P. D., & Campbell, M. (2025) · FEBS Journal · doi:10.1111/febs.70357 · Cited by 1
Cerebral blood flow as a mechanistic framework across neurological disease
Patel, S., Nischal, S. A., & Patel, N. K. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00269-2 · Cited by 1
Abedin, M. J., Lee, Y. F., Zhang, M., Russ, A., Gerashchenko, D., Bacskai, B. J., & Kastanenka, K. V. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261464208 · Cited by 1
Ferraro, M. G., Stanley, A., Lippiello, P., Pascarella, S., Speranza, L., Ricci, M., Volpicelli, F., Chieffi, S., & Miniaci, M. C. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2026-0085 · Cited by 1
“It has been proposed that BBB degradation and associated in fl ammation constitute early events in the neurodegenerative cascade underlying neuro-psychiatric disorders (Montagne et al. 2015; van de Haar et al. 2016).”
Wang, W., Xu, H., Wu, T., Zhang, Y., Tao, M., Zhao, X., Lu, J., Tang, X., Zhang, S., Zhang, Y., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1870764 · Cited by 1
Blood–brain barrier permeability assessment: from biomimetic models to multimodal imaging
Wang, M., Gan, L., Fan, Y., Duan, C., Zhu, Y., Luo, S., & Sun, Y. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500786 · Cited by 1
“Van de Haar et al. (2016) found no significant difference in leakage rate between global NAWM and cortical gray matter (GA) in early AD patients.”
Blood Pressure Variability and Alzheimer Disease Biomarkers
Lohman, T., Sible, I. J., Ma, Y., Pahlevan, N. M., & Nation, D. A. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.26768 · Cited by 1
scMustree: a multi-scale functional hierarchy for single-cell transcriptomic analysis
Xu, Y., Wang, S., Ding, L., Li, H., & Wang, J. (2026) · Bioinformatics · doi:10.1093/bioinformatics/btag672 · Cited by 1
The Ticking of the Epigenetic Clock: Antipsychotic Drugs in Old Age
Sfera, A., Osorio, C. P., Inderias, L., & Cummings, M. A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00122 · Cited by 1
In Vitro Blood-Brain Barrier Functional Assays in a Human iPSC-Based Model
Neal, E. H., Shi, Y., & Lippmann, E. S. (2019) · Neuromethods · doi:10.1007/978-1-4939-9228-7_1 · Cited by 1
A Targeted Association Study of Blood-Brain Barrier Gene SNPs and Brain Atrophy
Vacher, M., Porter, T., Milicic, L., Bourgeat, P., Doré, V., Villemagne, V. L., Laws, S. M., & Doecke, J. D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-210644 · Cited by 1
Newton, C. (2020) · Springer eBooks · doi:10.1007/978-3-030-30730-1_49 · Cited by 1
The Blood–Brain Barrier in Cognitive Decline and Alzheimer’s Disease
Nation, D. A., & McIntosh, E. C. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190634230.003.0012 · Cited by 1
Tzara, O., Simonsen, S. A., West, A. S., Karsdal, M. A., Iversen, H. K., & Henriksen, K. (2022) · Brain Injury · doi:10.1080/02699052.2022.2048692 · Cited by 1
Imaging Techniques to Study Tight Junctions
Ali, T. A., Akhtar, S., Nisar, S., Masoodi, T., Reddy, R. D., Bhat, A. A., & Haris, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-2415-8_4 · Cited by 1
Dysregulation of Porphyromonas gingivalis Agmatine Deiminase Expression in Alzheimer’s Disease
Hamdi, A., Baroudi, S., Gharbi, A., Babay, W., Laaribi, A. B., Kacem, I., Mrabet, S., Zidi, I., Klibi, N., Gouider, R., et al. (2024) · Current Alzheimer Research · doi:10.2174/0115672050327009240808103542 · Cited by 1
Simmons, J. (2019) · VTechWorks (Virginia Tech) · Cited by 1
Kilian, J. (2020) · eScholarship (California Digital Library) · Cited by 1
Cerebrovascular and Blood-Brain Barrier Impairments in Machado-Joseph Disease
Lobo, D. D. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Sasmita, A. O. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10403 · Cited by 1
Endothelial Vcam-1 As A Marker for Cerebrovascular Inflammation in Alzheimer’S Disease
Salian, V. S. (2023) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
Andersson, E., Wendt, T. S., Bergman, F., Isaxon, C., & Ansar, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.29.702473 · Cited by 1
Zhang, X. (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190208cz
Barron, M. (2018) · Nottingham ePrints (University of Nottingham)
iPSC-derived microglia as a model of immune dysfunction in neurodegenerative diseases
Bunga, A. (2018) · ORCA Online Research @Cardiff (Cardiff University)
Paschoal, A. M. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2020.tde-19032020-104417
Agostini, A. (2020) · Nottingham ePrints (University of Nottingham)
Neelaveni, J., Devasena, M. S. G., & Gopu, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822271-3.00002-5
Park, J. S., Choi, S.-H., Sohn, C., & Park, J. (2021) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2021.3104016
Canjels, L. P. W. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210831lc
Saeliw, T., Permpoon, T., Iadsee, N., Tencomnao, T., Sarachana, T., GREEN, D. J., & Sae‐Lee, C. (2022) · Research Square · doi:10.21203/rs.3.rs-1194570/v2
Causes and consequences of microvascular dysfunction: focus on the brain
Rensma, S. P. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201029sr
Imaging blood-brain barrier function in aging
Verheggen, I. C. M. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210601iv
New Understanding of BBB Impairments in Ageing and Neurodegenerative Diseases
Yang, X. (2020) · Alzheimer s Research & Therapy Open Access · doi:10.23880/artoa-16000113
Biomarkers in cerebrospinal fluid and blood aid diagnosis of dementia
Rosenberg, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823455-6.00001-8
Rosenberg, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823455-6.00002-x
Bae, J., Ge, Y., & Kim, S. (2022) · Veins and Lymphatics · doi:10.4081/vl.2022.10943
Glial Cells in Alzheimer’s Disease: Insights from Patient-Derived Models
Verkerke, M. L. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1838
Huang, S., Huang, X., Li, Z., Fu, F., & Yue, F. (2024) · Biophotonics and Immune Responses · doi:10.1117/12.3005107
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226955
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226976
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226979
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226958
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226970
La microfluidique appliquée à la purification des membranes plasmiques
Lecorgne, L. (2023) · theses.fr (ABES) · doi:10.70675/45ec7210z813cz4faez808cz7f9e8f5d8188
Ishizaka, H., Sekine, A., Naka, M., Nakano, S., Nagase, H., & Tsushima, Y. (2025) · Acta Radiologica Open · doi:10.1177/20584601251317629
Düzel, E., & Bernal, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-822240-9.00015-6
Imaging Alzheimer’s Retinopathy
Gaire, B. P., Koronyo, Y., Shi, H., Rentsendorj, A., Dumitrascu, O. M., Vit, J., Doustar, J., Black, K. L., Fuchs, D.-T. S., & Koronyo‐Hamaoui, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-72156-4_6
Choi, K. S., Choi, M., Park, M., & Jahng, G. (2025) · Investigative Magnetic Resonance Imaging · doi:10.13104/imri.2025.0001
Araújo-Filho, I. (2025) · Current Trends in Clinical & Medical Sciences · doi:10.33552/ctcms.2025.04.000579
Sleep and Human Health, Part B
Rusak, B. (2025) · Oxford University Press eBooks · doi:10.1093/med/9781605352978.003.0015
Imaging BBB dysfunction in brain disorders
Wang, D. J. J., & Shao, X. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32974-6.00001-x
MR Imaging Biomarkers in HIV associated Neurocognitive Impairment in the Era of cART
Chaganti, J. R. (2021) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/22527
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226952
Wang, K., Sun, C., Dumčius, P., Zhang, H., Liao, H., Wu, Z., Tian, L., Peng, W., Fu, Y., Wei, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23689694
Schröder, N., Schaffrath, A., Welter, J. A., Putzka, T., Griep, A., Ziegler, P., Brandt, E., Samer, S., Heneka, M. T., Kaddatz, H., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12195510
Additional file 1 of NX210c drug candidate peptide strengthens mouse and human blood-brain barriers
Chris, G., Rebergue, N., Fewell, G., Janigro, D., Godfrin, Y., Campbell, M., & Lemarchant, S. (2024) · Figshare · doi:10.6084/m9.figshare.27124205
Wachtel, J. (2024) · Gutenberg Open Science · doi:10.25358/openscience-10324
Swarbrick, S. (2019) · Loughborough University Research Repository (Loughborough University) · doi:10.26174/thesis.lboro.8272994
Shi, H., Koronyo, Y., Fuchs, D.-T., Sheyn, J., Wawrowsky, K., Lahiri, S., Black, K. L., & Koronyo‐Hamaoui, M. (2020) · Figshare · doi:10.6084/m9.figshare.13279800
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226949
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226946
Role of Cellular Senescence in Neurodegeneration: Mechanisms and Therapeutic Implications
Rashid, I., Kalandria, A., Kaur, N., Sharma, A., Qadir, S., Singh, R., & Ifaq, Q. (2024) · Journal of Pharma Insights and Research. · doi:10.5281/zenodo.11145036
Vinje, V., Zapf, B., Ringstad, G. A., Eide, P. K., Rognes, M. E., & Mardal, K.-A. (2024) · Figshare · doi:10.6084/m9.figshare.26611406
Wang, J., Fan, D.-Y., Li, H.-Y., He, C.-Y., Shen, Y.-Y., Zeng, G.-H., Chen, D.-W., Yi, X., Ma, Y.-H., Yu, J.-T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18482235
Verheggen, I. C. M., de Jong, J. J. A., van Boxtel, M. P. J., Postma, A. A., Verhey, F. R. J., Jansen, J. F. A., & Backes, W. H. (2020) · Figshare · doi:10.6084/m9.figshare.13161305
Self-citationOhene, Y., Harris, W. J., Powell, E., Wycech, N. W., Smethers, K. F., Lasič, S., South, K., Coutts, G., Sharp, J., Lawrence, C. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26580110
Investigating Synapse Function In Organotypic Hippocampal Slice Culture Models of Neurodegeneration
Humphrey, R. (2023) · Apollo (University of Cambridge) · doi:10.17863/cam.109149
The role of A20 in blood brain barrier maintenance
Ries, N. (2024) · Gutenberg Open Science · doi:10.25358/openscience-10155
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226967
Jiang, R., Smailović, U., Haytural, H., Tijms, B. M., Li, H., Haret, R. M., Shevchenko, G., Chen, G., Abelein, A., Gobom, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20226982
Metadata
- Authors
- van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H.
- Affiliations
- Maastricht University Medical Centre (NL)
- Leiden University Medical Center (NL)
- Leiden University (NL)
- ORCID
- Venue
- Radiology
- Published
- 2016-11
- Volume
- 281
- Issue
- 2
- Pages
- 527-535
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2415637550
- Cited by
- 601
- References
- 32
- Citations by year
- 2026: 37 · 2025: 56 · 2024: 66 · 2023: 65 · 2022: 81 · 2021: 89 · 2020: 64 · 2019: 50 · 2018: 42 · 2017: 36 · 2016: 13
- FWCI
- 25.63
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Radiology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Radiological Society of North America
- Internationale Stichting Alzheimer Onderzoek (10553)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- blood-brain barrier disruption, early Alzheimer's disease, dynamic contrast-enhanced MRI, Patlak graphical analysis, plasma volume, gray matter, normal-appearing white matter, deep gray matter, cognitive decline, Mini-Mental State Examination
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Blood Volume, Blood-Brain Barrier, Contrast Media, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Pilot Projects, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.